Cargando…
Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
Platinum (Pt)-based anticancer drugs such as cisplatin have been used to treat various cancers. However, they have some limitations including poor selectivity and toxicity towards normal cells and increasing chemoresistance. Therefore, there is a need for novel metallo-anticancers, which has not bee...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721113/ https://www.ncbi.nlm.nih.gov/pubmed/33299303 http://dx.doi.org/10.2147/DDDT.S275007 |